Skip to main content
. 2014 Sep 1;3(1):190–196. doi: 10.3892/mco.2014.405

Table V.

Plasma concentrations of IL-17 (ng/l).

Groups No. T0 T1 T2 T3 T4 P-value
I 15 20.8±7.3 26.5±6.7 32.5±5.2 33.3±8.2 30.2±8.3 <0.01
II 14 18.4±6.8 23.3±8.2 28.2±8.4 26.5±9.9 23.1±7.6 0.03
III 14 22.1±7.2 23.1±7.2 25.7±6.5 26.2±7.5 24.2±7.3 0.52
IV 14 19.6±8.6 21.8±7.6 22.4±7.3 22.7±5.3 21.3±6.2 0.79
P-value 0.60 0.38 <0.01 <0.01 0.01

Difference S IN IL-17 between groups by time period: T0, no significance. T1, no significance. T2, I VS. III, P=0.01; I VS. IV, P<0.01; AND II VS. IV, P=0.03. T3, I VS. II, P=0.02; I VS. III, P=0.02; AND I VS. IV, P<0.01. T4, I VS. II, P=0.01; I VS. III, P=0.03; AND I VS. IV, P<0.01. Difference S IN IL-17 between time periods compared TO T0 for each group: I, T0 VS. T1, P=0.03; T0 VS. T2, P<0.01; T0 VS. T3, P<0.01; AND T0 VS. T4, P<0.01. II, T0 VS. T2, P<0.01; AND T0 VS. T3, P=0.01. III and IV, no significance.